More employers could cover popular weight loss and diabetes drugs like Ozempic and Wegovy in 2024, allowing workers to avoid steep out-of-pocket costs, a new survey found.
Drugs like Ozempic and Wegovy can cost upwards of $1,000 a month without insurance, but the drugs’ ability to help employees’ health in the long term could lead more employers to cover them under medical plans.
Cognito Therapeutics, a neurotechnology company birthed out of MIT, is pioneering breakthrough technology that may be able to slow the progression of Alzheimer’s disease.
Health insurer Humana announced a succession plan for long-time chief executive officer Bruce Broussard who will retire next year and be replaced by Jim Rechtin, the current CEO of Envision Healthcare.
During this month, the healthcare community comes together to educate the world about breast cancer, spread awareness, and uplift those affected by it.
The full Ninth Circuit voted to hear the Biden Administration’s challenge to Idaho’s abortion ban during medical emergencies, voiding an earlier decision from three Trump-appointed judges on the court.